[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_101":102},"en-item",{"_9":10,"_10":11},"kind","item",{"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":31,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":-5,"_48":49,"_50":-5,"_51":-5,"_52":53,"_54":55,"_56":57,"_58":42,"_59":42,"_60":61,"_62":42,"_63":64},"id","wia2cl2nvaxiji5dpkxg5xgbt","revision",2,"title","US Nuclear Corp. 2026年Q1净亏损18.7万美元，现金流紧张","originalTitle","US NUCLEAR CORP. (0001543623) (Filer)","summary","US Nuclear Corp. 2026年3月31日止三个月净亏损187,086美元，较2025年同期净亏损560,232美元有所收窄，但收入下降至352,209美元。公司累计亏损达2,142万美元，现金流减少至67,318美元，总资产下降至163.9万美元。公司面临重大持续经营不确定性，且存在大量债务和关联交易风险。","reason","公司2026年Q1净亏损扩大，现金流紧张，资产和收入下滑，面临持续经营重大不确定性，且存在大量债务和关联交易风险。","source",{"_12":92,"_93":94,"_9":95,"_96":42,"_97":98,"_99":100},"links",{"_89":90,"_78":91},"publishedAt","2026-10-13T14:20:22.000Z","discoveredAt","2026-10-13T14:43:21.435Z","timelineAt","category","ai-products","tags",[83,84,85,86,87,88],"stockSymbols",[],"score",66,"selected",true,"channel","news","story",{"_73":74,"_16":75},"x","readingMode","full","author","language","body",{"_64":77,"_78":-5,"_79":80,"_81":82},"outline",[],"relatedStories",[76],"indexable","markdownAvailable","group",{"_65":66,"_45":67,"_68":69,"_70":71,"_72":69},"hasTranslation","bodyLanguage","zh","factId","fB_zsEvp3ESQ",{"_73":74,"_16":75},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","d6d0d810-bb6b-4bbc-aa45-0a2b167cd93e","EON Resources Inc. 财务困境持续",{"_73":74,"_16":75},"

美国证券交易委员会

华盛顿特区 20549

10-Q 表

☒ 根据《1934 年证券交易法》第 13 或 15(d) 条的季度报告

截至 3 月 31 日的季度

☐ 根据《1934 年证券交易法》第 13 或 15(d) 条的过渡报告

委员会文件编号：000-54617

$\"\"$

(注册人根据其章程指定的名称)

\n\n\n\n\n\n\n

特拉华州		45-4535739
州或其他司法管辖区		(美国国税局雇主
成立或组织		识别号码)

7051 Eton Avenue

Canoga Park, CA 91303

(主要执行办公室地址)

(818) 883-7043

(注册人的电话号码，包括区号)

通过勾选方框表明注册人(1)是否已提交根据《1934 年证券交易法》第 13 或 15(d) 条在前 12 个月内(或注册人需要提交此类报告的较短期间)要求提交的所有报告，以及(2)是否在过去 90 天内受到这些提交要求的约束。是 ☐ 否 ☒

通过勾选方框表明注册人是否已通过电子方式提交并将其发布在其公司网站上(如有)，并在前 12 个月内(或注册人需要提交和发布此类文件的较短期间)根据第 405 条《S-T 规则》(本章第 232.405 条)要求提交和发布每个交互式数据文件。是 ☒ 否 ☐

通过勾选方框表明注册人是否为大型加速申报者、加速申报者、非加速申报者或较小的报告公司。参见《交易法》第 12b-2 条中“大型加速申报者”、“加速申报者”和“较小的报告公司”的定义。

\n\n\n\n\n

大型加速申报者	☐	加速申报者	☐
非加速申报者	☒	较小的报告公司	☒
		新兴成长公司	☐

如果为新兴成长公司，请通过勾选方框表明注册人是否已选择不使用《证券法》第 7(a)(2)(B) 条规定的任何新修订的财务会计标准的延长过渡期。 ☐

通过勾选方框表明注册人是否为壳公司(根据《交易法》第 12b-2 条的定义)。是 ☐ 否 ☒

根据《法案》第 12(b) 条注册的证券：

\n\n\n\n\n\n

每类的名称		交易符号		每种证券注册的交易所名称
普通股		UCLE		场外交易：专家

截至 2026 年 10 月 2 日，注册人的普通股流通股数为 62,822,263 股。

第一部分
第 1 项。	财务报表（未经审计）	1
第 2 项。	管理层讨论与分析财务状况和经营成果	22
第 3 项。	关于市场风险的定量和定性披露	25
第 4 项。	控制和程序	25

第二部分
第 1 项。	法律诉讼	26
第 1A 项。	风险因素	26
项目 2.	未注册的股权证券销售及收益使用情况	26
项目 3.	优先证券违约	27
项目 4.	矿山安全披露	27
项目 5.	其他信息	27
项目 6.	附注	27
	签名	28

第一部分 - 财务信息

项目 1. 财务报表。

美国核能公司及子公司

简明合并资产负债表

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

	3月31日,			12月31日,
	2026			2025
	(未经审计)			(已审计)
资产
流动资产
现金	$	67,318			$	134,779
应收账款，净额		82,745				213,700
应收票据		38,916				39,966
存货，净额		1,005,770				1,083,083
预付费用和其他流动资产		-				5,630
流动资产总计		1,194,749				1,477,158

物业、厂房及设备，净额		-				524
投资		4,539				4,539
商誉		439,662				439,662
资产总计	$	1,638,950			$	1,921,883

负债及股东亏损

流动负债
应付账款	$	126,820			$	217,440
应计负债		1,180,201				1,171,321
高管薪酬应计		31,000				13,000
客户存款		65,581				117,496
应付票据，流动部分		234,580				181,924
应付股东票据		95,561				90,330
信贷额度		452,383				384,630
流动负债总计		2,186,126				2,176,141

长期负债
应付票据，扣除流动部分		117,895				184,433
可转换应付票据		75,000				75,000
长期负债总计		192,895				259,433

承诺及或有事项		-				-

负债总计		2,379,021				2,435,574

股东亏损：
普通股，面值 $0.0001；授权 100,000,000 股，已发行及流通在外 62,822,263 股和 62,822,263 股		6,283				6,283
待发行普通股 (593,556 股)		198,785				150,060
优先股，A 系列，面值 $0.0001，授权 10,000 股，已发行及流通在外 2,656 股和 2,656 股		266				266
额外实收资本		20,478,838				20,478,838
累计亏损		(21,424,243	)			(21,149,138	)
股东亏损总计		(740,071	)			(513,691	)
负债及股东亏损总计	$	1,638,950			$	1,921,883

附注是这些未经审计的简明合并财务报表的组成部分。

美国核能公司及子公司

简明合并经营表

(未经审计)

	截至
	3月31日,
	2026			2025

销售额	$	352,209			$	476,705
销售成本		197,214				127,788
毛利		154,995				348,917

经营费用
销售、一般及行政费用		300,898				872,797
总经营费用		300,898				872,797

经营亏损		(145,903	)			(523,880	)

其他收入 (费用)
利息费用		(41,183	)			(36,352	)
其他收入		-				-
其他收入 (费用)总计		(41,183	)			(36,352	)

所得税前亏损		(187,086	)			(560,232	)

所得税费用		-				-

净亏损	$	(187,086	)		$	(560,232	)
优先股股利		(88,019	)			(71,227	)
认股权证下行轮次规定的视同股利		-				-

归属于普通股股东的净亏损	$	(275,105	)		$	(631,459	)

加权平均已发行股份 - 基本及稀释		62,701,458				57,309,903

每股亏损 - 基本及稀释	$	(0.00	)		$	(0.01	)

附注是这些未经审计的简明合并财务报表的组成部分。

美国核能公司及子公司

股东权益变动表

(未经审计)

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

	普通股		普通股			优先股 A 系列		优先股	额外实收资本		累计亏损			股东权益总计
	股数		金额			应付		股数	金额		应付			资本		亏损	权益
2025年12月31日余额		62,822,263		$	6,283		$	150,060		2,656		$	266		$	-	$	20,478,838	$	(21,149,138	)	$	(513,691	)
优先股股利，以普通股支付		-			-			48,725		-			-			-		-		(48,725	)		-
优先股股利，以现金支付		-			-			-		-			-			-		-		(39,294	)		(39,294	)
净亏损		-			-			-		-			-			-		-		(187,086	)		(187,086	)

2026年3月31日余额		62,822,263		$	6,283		$	198,785		2,656		$	266		$		$	20,478,838	$	(21,424,243	)	$	(740,071	)

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

	普通股		普通 \n股			优先股 \nA 系列		优先 \n股	额外实收 \n资本		累计 \n亏损			股东 \n权益总计
	股数		金额			应付		股份	金额		应付			资本		赤字		权益
余额，2024年12月31日		52,712,778		$	5,271		$	45,813		-		$	-		$	2,006,000		$	16,763,076	$	(19,676,325	)	$	(856,165	)
发行普通股换取现金		1,000,000			100					-			-			-			49,900					50,000
发行普通股换取服务		850,000			85			-		-			-			-			56,015		-			56,100
发行普通股换取债务和利息		4,367,426			437			-		-			-			-			262,019		-			262,456
发行优先股		-			-			-		2,006			201			(2,006,000	)		2,005,799		-			-
优先股股利，以普通股支付		-			-			41,549		-			-			-			-		(41,549	)		-
优先股股利，以现金支付		-			-			-		-			-			-			-		(29,678	)		(29,678	)
发行认股权证换取服务		-			-			-		-			-			-			394,999					394,999
净亏损		-			-			-		-			-			-			-		(560,232	)		(560,232	)
余额，2025年3月31日		58,930,204		$	5,893		$	87,362		2,006		$	201		$			$	19,531,808	$	(20,307,784	)	$	(682,520	)

附注是这些未经审计的简明合并财务报表的组成部分。

US NUCLEAR CORP. 及其子公司

简明合并现金流量表

(unaudited)

	截至
	3月31日
	2026			2025

经营活动
净亏损	$	(187,086	)		$	(560,232	)
将净亏损调整为经营活动净现金使用的调整项：
折旧和摊销		524				360
发行普通股换取服务		-				56,100
发行认股权证换取服务		-				394,999

经营资产和负债的变动：
应收账款		130,955				290,413
应收票据		1,050				-
存货		77,313				(214,107	)
预付费用和其他流动资产		5,630				10,000
应付账款		(90,620	)			(3,630	)
应计负债		(30,414	)			54,553
应计薪酬		18,000				-
客户存款		(51,915	)			(120,942	)

经营活动净现金使用		(126,563	)			(92,486	)

融资活动
信贷额度下的净借款（偿还）		67,753				-
向股东发行应付票据所得款项		5,231				12,000
应付票据所得款项		27,000				-
偿还应付票据		(40,882	)			(31,865	)
发行普通股所得款项		-				50,000
融资活动提供的净现金		59,102				30,135

现金净增加（减少）额		(67,461	)			(62,351	)

现金
期初	$	134,779			$	130,840
期末	$	67,318			$	68,489

现金流量信息的补充披露
已付税款	$	-			$	-
已付利息	$	27,285			$	10,398

非现金披露：
发行普通股以转换债务和利息	$	-			$	262,046
应付优先股股利	$	48,725			$	41,549

附注是这些未经审计的简明合并财务报表的组成部分。

US NUCLEAR CORP. 及其子公司

简明合并财务报表附注

截至2026年3月31日的三个月

附注1 – 组织和列报基础

组织和业务线

US Nuclear Corp.，前身为 APEX 3, Inc.，（“公司”或“US Nuclear”）于2012年2月14日根据特拉华州法律组建。

2016年5月31日，公司与 Electronic Control Concepts（“ECC”）签署了一项资产购买协议，公司据此购买了 ECC 的某些有形和无形资产。

公司从事辐射检测和测量设备的开发、制造和销售。公司向全球消费者营销和销售其产品。

中期财务报表

本文件包含的未经审计的中期财务报表，系依据美国公认会计原则编制并以美元列示，由公司按照证券交易委员会（“SEC”）的规则和法规编制，未经审计。根据此类规则和法规，通常包含在依据公认会计原则编制的财务报表中的某些信息和附注披露已被浓缩或省略，尽管公司认为披露足以使所列示的信息不具误导性。

这些报表反映了所有调整，包括正常经常性调整，管理层认为这些调整对于公平列示其中包含的信息是必要的。建议将这些中期财务报表与公司截至2025年12月31日的年度财务报表及其附注一并阅读，附注包含在2026年6月25日提交的10-K表格年度报告中。公司在编制中期报告时遵循相同的会计政策。中期期间的经营结果并不代表年度结果。

持续经营

随附的合并财务报表系假设公司将继续作为持续经营主体而编制。公司截至2026年3月31日的三个月录得净亏损187,086美元，截至2026年3月31日累计亏损为21,424,243美元，这对其持续经营能力提出了重大怀疑。

公司作为持续经营主体的能力取决于其未来产生盈利运营的能力和/或获得必要的融资以履行义务并偿还正常业务运营产生的负债到期时的债务。管理层计划通过贷款和应付票据以及债务和权益证券的私募发行寻求额外资本。如果这些计划成功，将减轻对公司持续经营能力提出重大怀疑的因素。这些合并财务报表不包括因这种不确定性可能导致的已记录资产金额的可收回性和分类或负债金额和分类的任何调整。

附注2 – 重要会计政策摘要

合并原则

随附的合并财务报表包括公司及其全资子公司Optron Scientific Company、Overhoff Technology Corporation（“Overhoff”）及其全资子公司Electronic Control Concepts（“ECC”）的账户，系按照美国公认会计原则编制。所有重要的公司间交易和余额均已抵销。

估计的使用

管理层需做出估计和假设，以编制符合公认会计准则的财务报表。这些估计和假设会影响财务报表日资产和负债的列报金额，以及报告期内收入和费用的列报金额。实际结果可能与这些估计存在差异。由于涉及的主观性和判断程度，会计估计和假设可能对本公司具有重要影响。

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日和2025年三个月

现金及现金等价物

现金及现金等价物包括手头现金、定期存款、存单以及所有原始期限为三个月或更短的流动性极强的债务工具。截至2026年3月31日和2025年12月31日，不存在现金等价物。

信用风险集中度

可能使公司面临信用风险集中的金融工具包括现金及现金等价物。公司将现金存放在高质量的金融机构，有时可能超过联邦存款保险公司保险限额。公司未发生且不预期因该信用风险而产生任何损失。

应收账款

公司对应收账款可能发生的信用损失计提准备。管理层审查应收账款的构成，并分析历史坏账、客户集中度、客户信用状况、当前经济趋势及客户付款模式的变化，以评估这些准备是否充足。除分析未来潜在信用损失外，准备金还根据公司历史收款记录进行记录。管理层考虑应收账款的账龄、客户信用评级的变动，以及任何可能影响信用损失估计的行业特定因素和经济增长趋势。截至2026年3月31日和2025年12月31日，坏账准备分别为4,900美元和4,900美元。

存货

存货按成本（主要采用加权平均法确定）与可变现净值孰低法计价。管理层将存货成本与可变现净值进行比较，如果可变现净值较低，则计提减值准备，将存货账面价值减记至可变现净值。截至2026年3月31日和2025年12月31日，公司分别记录了47,128美元和47,128美元的滞销或过时存货减值准备。公司定期评估其存货是否存在滞销和/或过时项目。如果发现任何此类项目，将为其计提适当的减值准备，和/或将这些项目视为已发生减值。在截至2025年12月31日的十二个月中，公司开始实施将其在加利福尼亚州生产的产品的制造迁移至俄亥俄州Overhoff设施的计划。因此，由于运输存货的成本/效益不可行，公司对Optron的存货减记了589,177美元。公司正在探索通过向第三方出售存货来回收任何清算价值的方法。如果成功（全部或部分），公司将把存货销售所得款项在其财务报表中确认为收入。

美国核能公司及其子公司

合并财务报表附注

截至2026年及2025年3月31日的三个月

财产和设备

财产和设备按成本列示。维护和修理费用于发生时计入损益；增加、更新和改良支出予以资本化。当设备报废或以其他方式处置时，相关成本和累计折旧从相应账户中转出，任何利得或损失计入经营成果。设备折旧采用直线法计提，适用于绝大部分资产，预计使用寿命如下：

家具和固定装置		5年
租赁改良		租赁寿命与经济寿命孰低
设备		5年
计算机和软件		5年

长期资产

公司应用会计准则汇编（“ASC”）第360号主题财产、厂房和设备的规定，该主题涉及长期资产减值或处置的财务会计和报告。ASC 360要求在长期资产用于经营且存在减值迹象且预计由这些资产产生的未折现现金流量小于资产账面金额时，记录减值损失。在此情况下，损失根据账面金额超过长期资产公允价值的金额予以确认。对于拟处置的长期资产，损失按类似方式确定，但公允价值需扣除处置成本。根据2026年3月31日和2025年12月31日的审查，公司认为其长期资产没有减值。

商誉

商誉代表收购业务时购买价格超过其 underlying 净资产的金额。随附财务报表中的全部商誉余额源于公司于 2006 年对 Overhoff Technology Corporation 的收购。公司遵循 ASC 350，Goodwill and Other Indefinite Lived Intangible Assets，要求至少每年执行一次减值测试。截至 2025 年 12 月 31 日，公司执行了所需的减值分析， resulting in an impairment adjustment of $130,514。如果收入没有反弹且材料成本持续上涨，商誉减值分析中使用的重大估计值可能会在即将到来的一年中发生变化。

衍生金融工具

公司评估其所有协议，以确定此类工具是否包含衍生品或具有符合嵌入式衍生品特征的条款。对于作为负债核算的衍生金融工具，衍生工具在初始时按公允价值记录，然后在每个报告日重新估值，公允价值的变化在经营表中进行报告。对于基于股票的衍生金融工具，公司使用加权平均 Black-Scholes-Merton 期权定价模型在初始和后续估值日对衍生工具进行估值。衍生工具的分类，包括此类工具应记录为负债还是权益，在每个报告期末进行评估。衍生工具负债根据在资产负债表日后的 12 个月内是否可能要求衍生工具进行净现金结算，在资产负债表上分类为流动或非流动。在截至 2026 年 3 月 31 日和 2025 年 12 月 31 日的三个月期间，没有与我们的可转换应付票据相关的衍生工具负债。

US NUCLEAR CORP. AND SUBSIDIARIES

合并财务报表附注

截至 2026 年和 2025 年 3 月 31 日止的三个月

投资

公司按成本减去减值核算不具有可确定公允价值的权益证券投资。如果公司在相同或类似投资的有序交易中识别出可观察到的价格变化，公司按照 ASC 321 的规定，在可观察交易发生之日（“替代计量方法”）将该权益证券按公允价值计量。公司按照 ASC 323 的规定，采用权益法核算公司拥有 20% 或以上但不足 50% 的投资。

金融工具的公允价值

对于公司某些金融工具，包括现金、应收账款、应付账款、应计负债、客户存款和信贷额度，由于其到期日较短，账面金额接近其公允价值。此外，公司有一笔应付给股东的票据，其账面金额也接近公允价值。

可转换优先股

公司已授权发行 10,000 股 A 轮可转换优先股，每股可转换为 10,000 股公司普通股。优先股的股息率为每年 6%，在每个适用季度后的 90 天内按季度支付，且每持有一股 A 轮优先股可获得 1,200 股普通股。自 2026 年 1 月 31 日之后，公司有权但无义务按每股 1,000 美元赎回任何未偿付的 A 轮优先股，或将每股 A 轮优先股转换为 10,000 股普通股。 A 轮可转换优先股将于 2028 年 1 月 31 日到期，届时公司应将所有 A 轮优先股转换为每股 10,000 股普通股。

公司依据指引，并按照 ASC 480 和 ASC 470 对 A 轮可转换优先股进行会计处理，并确定 A 轮优先股将被视为股权交易。除股息外，唯一的强制性付款是到期时的转换，但由于转换是以公司自身的普通股结算，A 轮优先股不符合负债分类的标准。公司也考虑了将 A 轮可转换优先股分类为临时股权的要求；然而，A 轮股份并非由持有人自行决定可赎回。赎回权仅由公司管理层掌握，且强制性赎回不需要现金支付，因为公司可以选择以普通股结算。公司认为在到期时以现金赎回股份的可能性极低。此外，与关联方进行的债务清偿交易被视为资本交易。

收入确认

会计准则更新（“ASU”）第 2014-09 号，来自客户的合同收入（“Topic 606”），自 2018 年 1 月 1 日起对公司生效。公司的收入确认披露反映了受该新标准影响的更新会计政策。公司在实施 Topic 606 时，对未完结合同采用了“修正追溯法”过渡方法。由于销售主要来自向客户销售产品，且公司没有重大的交付后义务，因此该新标准并未导致在随附的合并财务报表上因应用该新标准而产生重大的收入确认。公司未对其此前报告的总收入进行调整，因为这些期间仍按照 Topic 605, 收入确认下的历史会计实务进行列报。

产品销售收入按照 Topic 606 进行确认，以合理反映向客户交付产品以换取预期对价，并包括以下要素：

●

与公司客户签署的、公司认为具有法律强制执行力的合同；

●

在各自合同中识别履约义务；

●

确定各自合同中每项履约义务的交易价格；

●

将交易价格分配给每项履约义务；以及

●

当公司满足每一项履约义务时，确认收入。

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日和2025年的三个月

这五个要素应用于公司的收入类别时，总结如下：

●

产品销售 - 当公司按照与客户约定的价格履行合同义务交付产品，且产品控制权通常已转移给客户时，确认收入。

在满足所有收入确认相关标准之前收到的款项，记录为客户预付款。

截至2026年3月31日和2025年的三个月，销售退回和折让分别为6,625美元和0美元。公司对所有销售提供一年保修。截至2026年3月31日和2025年的三个月，保修费用微不足道。公司不向客户提供无条件退货权、价格保护或任何其他让步。

关于按地区和产品线拆分的收入披露，请参阅附注10和11。

客户预付款

客户预付款代表客户在产品完成并发货前支付给公司的现金，且被视为可全额退款。

所得税

公司按照ASC主题740所得税的规定核算所得税。ASC 740要求公司采用资产和负债法核算所得税，即对可抵扣暂时性差异确认递延所得税资产，对应纳税暂时性差异确认递延所得税负债。暂时性差异是指资产和负债的账面金额与其计税基础之间的差异。当管理层认为递延所得税资产的一部分或全部很可能无法实现时，递延所得税资产会减记估值准备。递延所得税资产和负债根据税收法律和税率在生效日的变化进行调整。

根据ASC 740，只有当税务立场在税务检查中很可能被维持时，才将其确认为利益，并假定会进行税务检查。确认的金额是在检查中更有50%可能实现的最大税利益金额。对于未通过“很可能”测试的税务立场，不记录任何税利益。该采用对公司的合并财务报表没有影响。

基于股票的薪酬

公司按照FASB ASC主题718薪酬——股票薪酬的规定记录基于股票的薪酬。FASB ASC主题718要求公司以授予日的公允价值计量基于股票的员工薪酬成本，并在员工的必要服务期内确认费用。公司在经营业绩表中确认向员工和非员工发行的股票期权和其他基于股权的薪酬的授予日公允价值。

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日和2025年的三个月

基本和稀释每股收益

根据 ASC 主题 260，每股收益 计算每股收益。基本每股收益（“EPS”）基于流通在外普通股的加权平均股数。

稀释 EPS 基于假设所有具有稀释性的可转换股份和股票期权均已转换或行权。稀释程度通过应用库藏股法计算。根据此方法，期权和期权证被假设在期初（或较晚的发行时间）行权，并假设由此获得的资金在期间内按平均市场价格购买普通股。对于公司报告净亏损的期间，归属于普通股股东的稀释每股净亏损与归属于普通股股东的基本每股净亏损相同，因为如果具有稀释性的普通股的影响具有反稀释作用，则不假设其已发行。

	截至 3 月 31 日的三个月
	2026			2025
	普通股			普通股

分子：
净收益（亏损）	$	(187,086	)		$	(560,232	)
优先股股利		(88,019	)			(71,227	)
归属于普通股股东的净收益（亏损）	$	(275,105	)		$	(631,459	)
分母：
用于计算归属于普通股股东的每股净收益（亏损）的加权平均股数——基本		62,701,458				57,309,903
具有稀释性证券的影响		-				-
用于计算归属于普通股股东的每股净收益（亏损）的加权平均股数——稀释		62,701,458				57,309,903

归属于普通股股东的每股净收益（亏损）——基本	$	(0.00	)		$	(0.01	)
归属于普通股股东的每股净收益（亏损）——稀释	$	(0.00	)		$	(0.01	)

以下项目已从归属于普通股股东的稀释每股净收益（亏损）的计算中剔除，因为其影响将是反稀释的：

	截至 3 月 31 日的三个月
	2026		2025
	普通股		普通股
普通股股利		4,158,951		1,166,216
可转换票据及利息		54,000		2,418,000
可转换优先股		26,560,000		20,060,000
期权证		10,666,667		1,000,000
具有反稀释作用的证券总计		41,439,618		24,644,216

分部报告

FASB ASC 主题 280，分部报告，要求使用“管理法”模型进行分部报告。管理法模型基于公司管理层在公司内组织分部以制定经营决策和评估业绩的方式。公司确定其有两个可报告分部。见附注 10。

美国核能公司及子公司

合并财务报表附注

截至 2026 年和 2025 年 3 月 31 日的三个月

关联方

公司按照 ASC 850，《关联方披露》核算关联方交易。如果一方直接或间接或通过一个或多个中介，控制、被控制或与公司处于共同控制之下，则该方被视为与公司相关。关联方还包括公司的主要所有者、管理层、主要所有者和管理层的直系亲属，以及其他可能与公司进行交易的一方，如果一方控制或能对另一方的管理或经营政策产生重大影响，以至于交易的一方可能无法充分追求其自身的独立利益。能够对交易方的管理或经营政策产生重大影响的一方，或者如果其在交易方之一中拥有所有权利益并能对另一方产生重大影响，以至于一个或多个交易方可能无法充分追求其自身的独立利益，也是关联方。

重分类

某些前期金额被重新分类，以符合当期的列报方式。这些重分类对净亏损或股东权益没有影响。

近期会计公告

2024年11月，FASB发布了ASU 2024-03，即利润表费用拆分（DISE）标准（ASC 220-40）。该标准要求公共商业实体在附注中对某些费用项目进行拆分，为投资者提供更详细、透明的实体成本结构视图。ASU 2024-03的主要规定要求公共实体在中期和年度基础上披露（i）当期采购的存货金额，（ii）工资、薪金和福利总额，（iii）固定资产的折旧费用，（iv）无形资产的摊销，（v）折耗费用，（vi）未拆分费用的主要项目的定性描述，以及（vii）销售费用总额，包括实体定义为销售费用的部分。新准则自2026年12月15日之后的财政年度起生效。允许提前采用。一旦采用，该ASU很可能导致我们的合并财务报表中包含所需的额外披露。

2025年7月，FASB发布了ASU 2025-05，《金融工具——信用损失（主题326）：应收账款和合同资产的信用损失计量》。此次更新简化了组织应用当前预期信用损失（CECL）模型处理短期应收账款的方式。它允许所有实体使用一项实务例外，即无需预测未来的宏观经济条件。该标准自2025年12月15日之后的财政年度起生效，包括中期。公司于2025年12月31日采用了ASU 2025-05中的实务例外。在估计预期信用损失时，公司选择假设资产负债表日的当前经济条件在当前应收账款和合同资产的剩余期限内保持不变，而不是估计经济条件的变化。

附注3 – 存货

截至2026年3月31日和2025年12月31日的库存包括以下内容：

	2026		2025
原材料	$	552,025		$	543,795
在产品		430,866			456,938
产成品		22,879			82,350
库存总计	$	1,005,770		$	1,083,083

截至2026年3月31日和2025年12月31日，库存减值准备分别为37,351美元和37,351美元。

附注4 – 不动产和设备

截至2026年3月31日和2025年12月31日，不动产和设备的明细如下：

	2026			2025
家具和固定装置	$	104,674			$	104,674
租赁改良		50,091				50,091
设备		237,418				237,418
计算机和软件		40,340				40,340
		432,523				432,523
减去累计折旧		(432,523	)			(431,999	)
不动产和设备，净值	$	-			$	524

截至2026年3月31日和2025年12月31日的三个月内，折旧费用分别为524美元和1,304美元。截至2026年3月31日和2025年12月31日，公司拥有364,589美元的已完全折旧且仍在使用的不动产和设备。

美国核能公司及其子公司

合并财务报表附注

截至2026年和2025年3月31日的三个月

附注5 – 投资

MIFTEC

2018年8月3日，公司签署了一项协议，涉及MIFTEC Laboratories, Inc.（“MIFTEC”）、Magneto-Inertial Fusion Technologies, Inc.（“MIFTI”）的许可方以及公司。MIFTEC是MIFTI放射性核素技术的许可方。MIFTEC将聘请公司根据MIFTEC的规格和设计制造设备，并担任所制造设备的销售代表。公司将成为MIFTEC在北美和亚洲设备的独家制造商和供应商。此外，公司获得了MIFTEC 10%的股权。独家制造权和MIFTEC 10%股权的对价为500,000美元和公司普通股300,000股，估值594,000美元。公允价值基于2018年8月3日公司的股价确定。公司在2025年12月31日结束的年度的合并经营表中记录了MIFTEC 10%股权的价值为10,000美元，并将1,084,000美元记录为制造和供应权的取得。公司对该投资进行了减值评估，并确定在2019年12月31日结束的年度内需要减值9,000美元。截至2026年3月31日和2025年12月31日，该投资的账面价值分别为1,000美元和1,000美元。

MIFTI

2019年4月，公司还与 MIFTI 签订了一项合作协议，根据该协议，公司获得了某些独家制造和供应权，包括根据 MIFTI 设计用于发电的聚变反应堆，作为回报，公司需支付 500,000 美元，其中 100,000 美元在签署时支付，200,000 美元在协议签署后四个月内支付，200,000 美元在协议签署后九个月内支付。这 500,000 美元是购买 MIFTI 10% 股权的期权，价格为 2,700,000 美元，如果在该协议日期后 24 个月内完成。如果期权到期，MIFTI 应向公司发行 500,000 股普通股，并撤销协议中包含的所有其他独家权利。该期权已被撤销，公司收到了 500,000 股 MIFTI 普通股，这代表其 500,000 美元投资约 0.56% 的所有权。公司对该投资进行了减值评估，并确定在截至 2019 年 12 月 31 日的年度内需要减值 499,000 美元。2026 年 3 月 31 日和 2025 年 12 月 31 日，该投资的账面价值分别为 1,000 美元和 1,000 美元。

MIFTEC & MIFTI 合并

2025 年 9 月 10 日，MIFTEC Laboratories, Inc.（“MIFTEC”）和 Magneto-Inertial Fusion Technologies, Inc.（“MIFTI”）签署了一项合并协议，根据该协议，每 1 股 MIFTEC 普通股转换为有权接收 0.2 股 MIFTI 普通股。因此，公司拥有 1,022,710 股 MIFTI 普通股，具体构成如下：

	合并前普通股		合并后 MIFTI 普通股
MIFTI		622,710		622,710
MIFTEC		2,000,000		400,000
		2,622,710		1,022,710

GRAPHETON

2020 年 2 月 5 日，公司与加利福尼亚州公司 Grapheton, Inc.（“Grapheton”）签署了一份股票购买协议（“SPA”）。该交易于 2020 年 3 月 12 日完成。Grapheton 是一家专注于利用新材料系统构建被称为超级电容器的储能设备的初创公司。Grapheton 采用的技术已被证明在微电极阵列中具有卓越的电学和电化学性能，提供了显著的优势。

根据 SPA 的条款，公司将在两年内收购 Grapheton 的 2,552 股普通股。在交割时，公司发行了 1,452 股 Grapheton 普通股，价值 235,000 美元，以及 858,896 股公司普通股，价值 601,227 美元。

在 SPA 交易中，2021 年第二季度，公司额外收到了 1,100 股 Grapheton 普通股，以换取公司额外发行 1,121,071 股普通股，价值 633,405 美元。此外，Grapheton 履行了业绩对赌条款的要求，公司有义务支付第一笔业绩对赌款项 192,500 美元。该金额在随附的合并资产负债表中记录为应计费用。

根据 SPA 交割两周年之日由第三方估值师对公司的普通股进行的估值，可能向 Grapheton 额外发行公司的普通股以进行“调整”。

公司目前拥有 Grapheton 35.2% 的股权，并按照 ASC 323 的规定采用权益法核算其对 Grapheton 的投资。

US NUCLEAR CORP. 及其子公司

合并财务报表附注

截至 2026 年和 2025 年 3 月 31 日的三个月

关于 Grapheton 截至 2026 年 3 月 31 日的三个月的信息如下：

流动资产	$	42,608
总资产		717,489
流动负债		3,156,887
总负债		3,156,887
股东权益总额		(2,439,398	)

收入	$	3,299
销货成本		3,975
营业费用		155,605
其他费用		-
净亏损		(156,281	)

公司评估了此项投资，并在截至 2026 年 3 月 31 日的三个月内确认了归属于权益投资的损失 $0。截至 2026 年 3 月 31 日，该投资的账面价值为 $0。

附注 6 – 应付票据

在收购 ECC 资产的交易中，公司向 ECC 所有者签发了一张应付票据。该票据按年 5% 的利率计息，要求每季度支付本金和利息 $4,518，并于 2021 年 4 月 15 日到期。截至 2026 年 3 月 31 日和 2025 年 12 月 31 日，该应付票据的未偿余额分别为 $0 和 $5,272。

2020 年 12 月 26 日，公司持有的信贷额度已到期，根据信贷额度协议的条款，该额度已转换为可随时要求的应付票据。该债务按每天 $10.89 的利率计息，直至银行收到全额付款。截至 2025 年 12 月 31 日，该应付票据的未偿余额为 $0。

2024 年 9 月 30 日，公司与 Gold Team Inc.（公司 CEO 拥有的公司）签署了一张金额为 $300,000 的本票。该票据按年 7.2% 的利率计息，按季度支付，并于 2027 年 10 月 1 日到期。2025 年 9 月 30 日，该票据的本金余额转换为 300 股公司 A 系列可转换优先股，利息余额 $16,200 以现金偿还。截至 2025 年 12 月 31 日，该应付票据的未偿余额为 $0。

2024 年 9 月 30 日，公司与 Robert Goldstein（公司 CEO）签署了一张金额为 $350,000 的本票。该票据按年 7.2% 的利率计息，按季度支付，并于 2027 年 10 月 1 日到期。2025 年 9 月 30 日，该票据的本金余额转换为 350 股公司 A 系列可转换优先股，利息余额 $18,900 以现金偿还。截至 2025 年 12 月 31 日，该票据的本金和利息余额为 $0。

2024 年 9 月 30 日，公司前任 CFO Richard Landry 同意将公司欠他的 $150,000 累计薪酬转换为一张三年期的本票。该票据按年 7.2% 的利率计息，按季度支付，并于 2027 年 10 月 1 日到期。截至 2026 年 3 月 31 日，该票据的本金和利息余额为 $144,900。

2024 年 10 月 29 日，公司签署了一张金额为 $110,000 的应付票据。该票据按非年化利率 $31,900 计息，需每周支付 78 期 $1,819，直至付清。截至 2025 年 12 月 31 日，该票据的本金和利息余额为 $0。

2024 年 10 月 31 日，公司签署了一张金额为 $79,400 的应付票据，并包含 $2,374 的发行费。该票据按非年化利率 $22,153 计息，需每周支付 65 期 $1,562，直至付清。截至 2026 年 3 月 31 日，该票据的余额为 $0。

在截至 2024 年 12 月 31 日的十二个月内，公司从 Averox（关联方）处收到 $150。该票据可随时支付且不计息。

2025年12月18日，该公司签订了一笔金额为210,000美元的应付票据。该票据的非年化利息为60,900美元，将支付80次，每次3,386.25美元，每周支付一次，直至全部还清。截至2026年3月31日，该票据的本金和利息余额为175,875美元。

在截至2025年12月31日和2024年12月31日的十二个月内，该公司分别从关联方Cali From Above处获得2,050美元和2,500美元。截至2026年3月31日，该票据的余额为4,550美元，为可随时要求偿还且不计息的票据。

2026年3月31日，该公司签订了一笔金额为27,000美元的应付票据。该票据的非年化利息为7,560美元，将支付67次，每次516美元，每周支付一次，直至全部还清。截至2026年3月31日，该票据的本金和利息余额为27,000美元。

下表总结了截至2026年3月31日的应付票据的短期和长期部分：

应付票据总额	352,475
减：短期部分	(234,580	)
长期部分，净额	117,895

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日及2025年3月31日的三个月

可转换票据

2024年4月17日，公司于2022年5月5日和2022年10月10日发行的可转换票据的持有人同意根据票据的第2号修正案将到期日延长至2024年12月31日。作为延长到期日的对价，票据1的本金余额增加了50,000美元，票据2的本金余额增加了20,000美元。在截至2025年12月31日的十二个月内，公司以262,046美元的本金和利息换取了4,367,426股普通股，且这两张票据已全部还清。

2024年12月20日，公司通过Digital Trust, LLC（Michael Hastings（公司首席财务官）拥有的个人退休账户的托管人）收到72,000美元，与可转换票据有关。该贷款期限为62个月，年利率为6%，每季度支付利息。该票据在生效日后六个月即可随时转换，转换率为每12,000美元的本金和应付利息可转换为200,000股普通股。2025年6月18日，为鼓励转换该票据，公司修改了转换条款，规定如果贷款人于2025年9月30日前发出书面转换通知，贷款人有权以0.05除以转换金额的比率转换未偿还余额。贷款人接受了该激励措施，2025年6月23日，公司向其首席财务官发行了1,440,000股普通股，以支付72,000美元的本金。转换后，该票据的本金被视为全部还清，截至2026年3月31日，仍有2,160美元的应付利息未支付。公司根据ASC 470-20评估了该交易，并确认了12,000美元的激励费用，代表了额外考虑的公允价值。

2024年12月20日，公司收到了一名股东提供的72,000美元，该款项与可转换票据相关。该贷款期限为62个月，年利率为6%，每季度支付利息。该票据在生效日后六个月即可随时转换，转换率为每12,000美元的本金和应付利息可转换为200,000股普通股。2025年6月18日，为激励转换票据，公司修改了转换条款，规定如果贷款人于2025年9月30日前发出书面转换通知，贷款人有权以0.05除以转换金额的比率转换未偿还余额。贷款人接受了该激励措施，2025年6月23日，公司发行了1,440,000股普通股，以支付72,000美元本金。转换后，票据上的本金被视为全额支付，截至2026年3月31日，仍有1,080美元的应付利息未支付。公司根据ASC 470-20评估了该交易，并确认了12,000美元的激励费用，代表了额外考虑的公允价值。

2025年10月31日，公司签订了一份为期两年的50,000美元的期票。该期票年利率为24%，到期日为2027年10月31日，需一次性支付75,000美元。到期时，贷款人有权全额偿还期票或选择以每股2.50美元的价格购买公司目前持有的30,000股MIFTI普通股，总价值为75,000美元。

2025年12月18日，公司签订了一份25,000美元的期票。该期票年利率为24%，每月支付2%的利息，直至到期日2027年12月18日一次性支付37,500美元。到期时，贷款人有权以每股1.50美元的价格购买公司持有的25,000股MIFTI股票，总价值为37,500美元。如果贷款人在到期日前选择转换，应付利息将根据较短的期票期限进行调整，股价也将相应调整，以确保贷款人获得25,000股MIFTI股票。

下表总结了我们未偿还可转换票据的某些细节：

	2026年3月31日
到期日	本金金额		合同利率			规定利率	违约利率		有效利率率
2030年2月20日	$	-		$	1,080		6	%		12	%	6.17	%
2030年2月20日	$	-		$	2,160		6	%		12	%	6.17	%
2027年10月31日	$	50,000		$	5,208		24	%		24	%	26.82	%
2027年12月18日	$	25,000		$	1,563		24	%		24	%	26.82	%

应付股东的应计票据

CEO兼主要股东Robert Goldstein曾多次向公司提供资金以支付一般运营费用。这些贷款由无担保、无息票据证明，可随时偿还。截至2026年3月31日和2025年12月31日，所欠金额分别为90,330美元和90,330美元。

CFO Michael Hastings曾多次向公司提供资金以支付一般运营费用。这些贷款由无担保、无息票据证明，可随时偿还。截至2026年3月31日和2025年12月31日，所欠金额分别为5,231美元和0美元。

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日及2025年3月31日的三个月

2026年3月31日和2025年12月31日所有贷款和应付票据的到期期限如下：

截至12月31日的年度	2026年3月31日		2025年12月31日
2025	$	-		$	272,254
2026		233,404			259,433
2027		289,632			-
2028		-			-
2029		-			-
之后		-			-
	$	523,036		$	531,687

第7号注释 – 信用额度

截至2026年3月31日，公司有三个信用额度，最高借款金额为50万美元，利率在5.5%至55.0%之间。截至2026年3月31日和2025年12月31日，这些信用额度下的未偿金额分别为452,383美元和384,630美元。

第8号注释 – 租赁

公司在合同开始时确定合同是否是租赁或包含租赁，并确定该租赁是否符合融资租赁或经营租赁的分类标准。当可用时，公司使用租赁中的隐含利率将租赁付款折现为现值；然而，公司大部分租赁并未提供可确定的隐含利率。因此，公司必须根据其增量借款率的估计值对租赁付款进行折现，该估计值基于类似债务的利率。

公司从Gold Team Inc.租赁其当前设施，Gold Team Inc.是一家由公司首席执行官拥有的公司，拥有位于加利福尼亚州Canoga Park和俄亥俄州Milford的地点。租赁每年4月30日到期，公司已行使了额外12个月的续租选项。新租赁不超过12个月；因此，公司根据ASC 842选择了短期租赁排除。2024年10月1日，Gold Team同意在2025年7月1日前免收两个物业的租金，且在截至2025年6月30日的六个月期间内未计提或支付任何租赁费用。2025年6月30日之后，俄亥俄州Milford的租金费率降低至每月6,000美元，第一次付款于2025年7月1日到期。加利福尼亚州Canoga Park的租赁按月续签，GoldTeam同意继续免收加州设施的租金，直至Gold Team另行通知。自2019年1月1日起，公司采用了ASC 842租赁的规定。

截至2026年3月31日的三个月内，租赁费用分别为18,000美元和0美元。截至2026年3月31日和2025年3月31日的三个月内，经营租赁的现金支付分别为18,000美元和0美元。截至2026年3月31日，加权平均剩余租赁期限为0.1年，加权平均折现率为8%。

美国核能公司及其子公司

合并财务报表附注

截至2026年3月31日和2025年3月31日的三个月

第9号注释 – 股东权益

普通股

在截至2026年3月31日的三个月内，公司未发行任何普通股。

在截至2025年3月31日的三个月内，公司发行了：

●

650,000股普通股，价值42,900美元；以及

●

4,367,426股普通股，价值262,456美元，用于偿还可转换债务及利息；以及

●

200,000股普通股，作为服务费用支付给顾问，价值13,200美元。公允价值基于授予日公司的股价；以及

●

1,000,000股普通股，以现金支付，价值50,000美元。公允价值基于授予日公司的股价；以及

可转换优先股，A系列

在2024年11月27日，公司修订了其公司章程，以授权发行A系列可转换优先股。此类A系列优先股的股份数量为10,000股，面值为0.0001美元，占公司章程中授权的5,000,000股优先股（面值为0.0001美元）的一部分。A系列优先股的每股市值为1,000美元（“面值”）。A系列优先股的每位持有人都有权在向公司董事会提交书面通知后，将1股A系列优先股转换为公司10,000股普通股，具体根据董事会建立的任何程序进行转换。A系列优先股的持有人有权获得年度股息，按季度支付（即每年每三个月支付一次），在适用季度的最后一天后90天内支付，并根据需要按比例分配（a）持有人面值的6%，按该持有人持有的A系列可转换股份总数计算，以现金支付，以及（b）每持有1股A系列优先股，支付1,200股普通股。A系列优先股的持有人有权就公司普通股股东投票的任何事项进行投票，每1股A系列优先股在完全转换的基础上相当于10,000股普通股。

在截至2026年3月31日的三个月内，公司未发行任何优先股。

在截至2025年3月31日的三个月内，公司发行了：

●

300股优先股，用于转换应付租金300,000美元；

●

375股优先股，用于转换应付薪酬375,000美元；

●

1,203股优先股，用于转换股东借款1,203,000美元。

●

128股优先股，以现金128,000美元发行。

截至2026年3月31日，公司累计应计现金股息168,717美元，以及按公允价值198,786美元计算的4,158,950股普通股股息。所有当前的A系列优先股持有人同意将截至2026年6月30日的应计利息支付推迟。

美国核能公司及其子公司

合并财务报表附注

截至2026年和2025年3月31日的三个月

额外资本公积

在截至2026年和2025年3月31日的三个月内，公司分别记录了0美元和394,999美元的额外资本公积，以确认为服务发行的认股权证的公允价值。

认股权证

2025年1月1日，该公司发行了两份相同的无现金认股权证协议，用于咨询服务，每份认股权证的持有者有权在三年期限内以每股0.08美元的行权价购买最多2,500,000股普通股。在发行日，行权价高于授予日底层股票的公允市场价格，因此没有内在价值。发行时的公允价值为394,999美元。这些认股权证被归类为权益工具，发行时的公允价值是使用Black Scholes定价模型计算的。估值中未使用重大不可观察输入值，也无需进行重大调整。因此，该公司认为公允价值计量属于ASC 820层级中的第二层级。尚未确定尚未行权的认股权证的具体数量，但预计不会超过可发行股份数量。

2025年6月6日，该公司以无现金方式行权了1,147,059份认股权证，向第三方发行了1,147,059股普通股。

On September 1, 2025, the Company issued five identical cashless warrant agreements for services, entitling each holder to acquire an aggregate of 5,500,000 common shares at an exercise price of $0.06 for a three-year term. On the date of issuance, the exercise price was above the fair market value of the underlying shares on the grant date, resulting in no intrinsic value. The fair value at issuance was $129,250. These warrants are equity classified and the fair value at issuance was calculated using the Black Scholes pricing model. No significant unobservable inputs were used in the valuation, and no material adjustments were required. As such, the Company believes the fair value measurement falls within Level 2 of the ASC 820 hierarchy.

The Company’s warrants are classified as equity, and their value is carried in the additional paid-in capital account in the stockholders’ equity section of the balance sheet. The following table summarizes the activity related to warrants outstanding:

							Weighted
				Weighted			Average
				Average			Remaining	Aggregate
	Warrants			Exercise			Contractual	Intrinsic
	Outstanding			Price			Life	Value
Outstanding, December 31, 2024		1,000,000			$	0.04		3.78	$	39,000
Granted		11,013,726
Forfeited		(200,000	)
Exercised		(1,147,059	)
Outstanding, December 31, 2025		10,666,667			$	0.07		2.33	$	-
Granted		-
Forfeited		-
Exercised		-
Outstanding, March 31, 2026		10,666,667			$	0.07		2.09	$	11,333
Exercisable, March 31, 2026		10,666,667			$	0.07		2.09	$	11,133

The following table summarizes information about outstanding and exercisable warrants as of March 31, 2026.

Outstanding and Exercisable
Number of Warrants	Exercise Price
5,666,667	$	0.06
5,000,000	$	0.08
10,666,667

US NUCLEAR CORP. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

Note 10 – Segment Reporting

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company has two reportable segments: Optron and Overhoff. Optron is located in Canoga Park, California and Overhoff is located in Milford, Ohio. The assets and operations of the Company’s acquisition of the assets of Electronic Control Concepts are included with Overhoff in the table below.

Although the reportable segments use similar production processes for the Company’s hardware and software products and services, each one is managed separately to better align with the type of product manufactured. Our Optron facility produces radiation monitors, while the Overhoff facility manufactures tritium monitors. Both facilities offer calibration and repair services to the respective monitor systems or devices. The Company currently evaluates the performance of its reportable segments based on net sales and operating income. The Company’s Chief Operating Decision Maker (CODM) does not utilize any additional profit/loss metrics or any detailed asset allocations as part of the overall analysis, as the Company does not currently have these specific details available for review. While efforts are being made to enhance our internal metrics and reporting processes, currently, a complete suite of expense metrics for evaluating the effectiveness of our resource allocation across all segments is not fully operational. We are exploring project management tools and centralized platforms to integrate data from various sources and improve visibility into resource utilization. For each reporting segment, the Manager of Operations reports to the CODM, who is the Company’s CEO, Robert Goldstein.

The following tables summarize the Company’s segment information for the years ended March 31, 2026, and 2025:

	March 31,
	2026			2025
Sales
Optron	$	97,090			$	86,217
Overhoff		255,119				390,488
Corporate		-				-
	$	352,209			$	476,705

Gross profit
Optron	$	37,595			$	46,931
Overhoff		117,400				301,986
Corporate		-				-
	$	154,995			$	348,917

Income (loss) from operations
Optron	$	21,219			$	(83,329	)
Overhoff		(122,690	)			56,148
Corporate		(44,432	)			(496,699	)
	$	(145,903	)		$	(523,880	)

Interest Expenses
Optron	$	5,087			$	2,046
Overhoff		30,253				20,151
Corporate		5,843				14,155
	$	41,183			$	36,352

Net income (loss)
Optron	$	16,132			$	(85,375	)
Overhoff		(152,944	)			35,997
Corporate		(50,275	)			(510,854	)
	$	(187,086	)		$	(560,232	)

US NUCLEAR CORP. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

	As of March 31,
	2026		2025
Total Assets
Optron	$	31,722		$	912,495
Overhoff		1,601,945			1,566,818
Corporate		5,283			18,517
	$	1,638,950		$	2,497,830

Goodwill
Optron	$	-		$	-
Overhoff		439,662			570,176
Corporate		-			-
	$	439,662		$	570,176

Note 11 – Geographical Sales

Net geographical sales are based on the location of customers of both reportable segments. Operating income for each geographic segment consists of net sales to third parties. The geographical information provided to the Company’s chief operating decision maker for the purpose of making decisions and assessing segment performance excludes asset information.

The geographical distribution of the Company’s sales for the three months ended March 31, 2026, and 2025 is as follows:

	2026		2025
Geographical sales
North America	$	203,461		$	446,377
Asia		30,064			24,954
South America		-			-
Other		118,684			5,374
	$	352,209		$	476,705

Note 12 – Concentrations

For the three months ending March 31, 2026, two customers accounted for 26% and 18% of the Company’s sales. At March 31, 2026, two customers accounted for more than 10% of the accounts receivable balance, 35%, and 20%, respectively.

For the three months ended March 31, 2025, two customers accounted for 29% and 35% of the Company’s sales.

No vendors accounted for more than 10% of the Company’s purchases for the three months ended March 31, 2026, and 2025.

Note 13 – Related Party Transactions

The Company leases its current facilities month-to-month from Gold Team Inc., a company principally owned by the Company’s CEO, which owns both Canoga Park, CA and Milford, Ohio locations. Rent expense for the three months ended March 31, 2026, and 2025 was $18,000 and $0, respectively. As of March 31, 2026, and March 31, 2025, amounts payable to Gold Team Inc. in connection with the above leases was $0. (See Note 8).

During the three months ending March 31, 2026, the Company received an aggregate of $5,231 in on demand, non-interest loans from its CFO. (See Note 6)

On December 1, 2025, the Board of Directors approved monthly salaries to its Chief Executive Officer and Chief Financial Officer for $4,000 and $2,000, respectively. Salaries will be accrued, beginning on January 1, 2026, but not be paid until future authorization by the Board. As of March 31, 2026, and March 31, 2025, the Company had accrued compensation payable to its CEO of $31,000 and $13,000, respectively.

US NUCLEAR CORP. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

On September 30, 2025, the Company’s CEO converted a $300,000 note payable into 300 Series A Convertible Preferred stock of the Company. (See Note 9)

On September 30, 2025, Gold Team Inc., a company principally owned by the Company’s CEO, converted a $350,000 note payable into 350 Series A Convertible Preferred stock of the Company. (See Note 9)

Note 14 – Subsequent Events

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were available to be issued and has determined that no material subsequent events exist other than the following:

On April 10, 2026, the Company entered into a note payable in the amount of $200,000 with a related party. The note bears interest at 11.24% per annum and matures on April 10, 2056, with monthly payments of $2,057 due monthly. Upon closing, the parties agreed to a loan fee of $12,000 and was deemed advanced by the lender and added to the principal balance.

On April 16, 2026, Michael Pope notified the Company of his decision to resign as a member of the Board of Directors of the Company. Mr. Pope’s decision to resign was to pursue other opportunities and did not result from any disagreement with the Company regarding any matter relating to our operations, policies, or practices.

On June 23, 2026, the Company received $40,000 in cash from its CFO. The note is considered on demand and non-interest bearing.

On July 1, 2026, the Company received Notices of Default on its two Demand Line of Credit Notes dated December 5, 2011, with US Bank. The principal and interest became due and payable on June 30, 2026, and as of July 1, 2026, the interest rate will accrue at the default rate of 5% per annum, plus the interest rate otherwise payable.

On July 16, 2026, the Company issued a promissory note payable to a third party in the principal amount of $50,000. The note bears interest at an annual rate of approximately 24%, with interest accruing monthly at a rate of 2.0%. All principal and accrued interest are due in a lump-sum payment of $75,000 at maturity on July 1, 2028. The note contains multiple settlement and conversion options available to the lender at maturity, in lieu of a cash settlement.

Conversion terms

●

MIFTI Share Purchase Option: The lender maintains the right to purchase 75,000 common shares of MIFTI currently held by the Company at an exercise price of $1.00 per share.

●

Company Stock Conversion Option: The lender maintains the right to settle the outstanding note obligation in exchange for 1,000,000 shares of the Company’s common stock at a designated price of $0.75 per share.

On August 4, 2026, the Company received $5,000 in cash from its CFO. The note is considered on demand and non-interest bearing.

On August 12, 2026, the Company entered into a note payable in the amount of $253,500 to consolidate two prior outstanding notes with the lender. At closing, $183,442 was applied to the balances of the existing notes and the Company received $70,058 in net proceeds. The note bears non-annualized interest of $63,375 (approximately 29.86% annually) and 80 payments of $3,961 are to be paid weekly until paid in full.

On August 31, 2026, the Company entered into a Multi-party Netting and Offset Agreement whereby certain related party transactions resulting from various agreements, transactions, loans, accounts payable, accounts receivable, and other obligations have been settled. The following reflects the amounts settled/netted between parties.

US NUCLEAR CORP. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

Related Party Loans¹

LENDER	BORROWER	AMOUNT AS OF 8/31/2026
Cali From Above	Overhoff		2,500.00
Overhoff Technology	Averox		(14,000.00	)
Optron Scientific	Averox		(23,720.25	)
Cali From Above	Optron		2,050.00
Averox	US Nuclear		150.00
Electronic Control Concepts	Averox		(2,245.50	)
	Total, Due to Cali From Above		4,550.00
	Total, Due from Averox		(39,815.75	)
Offset against Shareholder Loans Owed to Robert Goldstein			(35,265.75	)

Shareholder Loans

LENDER	BORROWER	AMOUNT AS OF 8/31/2026
Goldstein	Overhoff Technology		23,400.00
Goldstein	Optron Scientific		76,419.20
US Nuclear	Goldstein		(6,288.39	)
Electronic Control Concepts	Goldstein		(3,201.00	)
	Total, Due to Goldstein		90,329.81
	Offset		(35,265.75	)
	Balance, Due to Goldstein		55,064.06

¹	Robert Goldstein holds a controlling interest in Averox. Cali From Above is a wholly owned subsidiary of Averox.

On September 16, 2026, the Company issued a promissory note payable to a third party in the principal amount of $30,000. The note bears interest at an annual rate of approximately 24%, with payments of $3,600 semi-annually ($3,600 every six months) to accrue until paid as a lump sum of $37,200 at maturity on September 16, 2027.

The note contains multiple settlement and conversion options available to the lender at maturity, in lieu of a cash settlement:

●

MIFTI Share Purchase Option: The lender maintains the right to purchase 30,000 common shares of MIFTI currently held by the Company at an exercise price of $1.00 per share. The right to purchase is in effect for the full twelve-month term of the Note, plus an additional six months after the maturity date.

On September 30, 2026, the Company and a note holder agreed to amend the $150,000 promissory note executed on September 30, 2024, modifying the payment terms of the Agreement. Beginning October 15, 2026, the Company will make eighteen payments of $2,000 monthly and beginning on April 15, 2028, the Company will make $6,000 monthly payments until all principal and interest are paid in full. The Maturity date has been extended to September 30, 2030.

Effective October 1, 2026, the Company and its shareholders have agreed to amend the rights of the holders of Series A Preferred Stock so that the percentage of common stock to which such holders are entitled shall be reduced from twelve percent (12%) to nine percent (9%) so that each holder of Series A Preferred Stock shall be entitled to receive an annual dividend, payable quarterly, equal to either (a) six percent (6%) of such holder’s Stated Value, payable in cash, or (b) nine percent (9%) of such holder’s Stated Value, payable in shares of common stock.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand US Nuclear Corp, our operations and our present business environment. MD&A is provided as a supplement to—and should be read in conjunction with—our consolidated financial statements and the accompanying notes included in this Quarterly Report on Form 10-Q. The audited financial statements for our fiscal year ended December 31, 2024, filed with the Securities Exchange Commission on Form 10-K on June 25, 2025, should be read in conjunction with the discussion below. This discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results may differ materially from those anticipated in these forward-looking statements. In the opinion of management, all material adjustments necessary to present fairly the results of operations for such periods have been included in these unaudited financial statements.

We were incorporated in Delaware on February 14, 2012, and on March 2, 2012, we filed a registration statement on Form 10 to register with the U.S. Securities and Exchange Commission as a public company. We were originally organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation.

Since our acquisition of Overhoff Technology in 2006, we have had discussions with other companies in our industry for an acquisition. While we targeted Overhoff due to its unique position in the tritium market, we had not commenced an acquisition since our Overhoff Technology acquisition; we believe in part the reason was due to lack of additional capital, our status as a privately held entity at the time, and focus on developing our own products. We will seek out companies whom our management believes will provide value to our customers and will complement our business. We will focus on diversifying our product line into a larger range so that our customers and vendors may have a more expansive experience in type, choice, options, price and selection. We also believe that with a more diverse product line we will become more competitive as our industry is intensely competitive.

Generally, our product concentration places a heavy reliance on our Overhoff Technology division. During the three months ending March 31, 2026, we derived 61% of our total revenues from sales made by Overhoff. Our international revenues were 42% of our total revenue during the three months ended March 31, 2026. We expect this to increase over time as we continue to field new order inquiries and engage new customers overseas. We believe that South Korea and China will likely be a larger contributor to revenue within the next few years. While we maintain steady growth domestically, the international side of our business may be a larger component as nuclear technology and rapid development for clean energy grows abroad. Additionally, the Company relies on continued growth and orders from CANDU reactors (Canada Deuterium Uranium), and rapid development of the next generation of nuclear reactors called Molten Salt Reactors, (MSR) and Liquid-Fluoride Thorium Reactors (LFTR), all of which purchase tritium detection and monitor products. There can be no assurances as to our growth projections and our risk profile as we depend upon increased foreign customers for business.

For the next twelve months, we anticipate we will need approximately $5,000,000 in additional capital to fund our business plans. If we do not raise the required capital, we may not meet our expenses and there can be no assurance that we will be able to do so and if we do, we may find the cost of such financing to be burdensome on the Company. Additionally, we may not be able to execute on our business plans due to unforeseen market forces such as lower natural gas prices, difficulty attracting qualified executive staff, general downturn in our sector or by competition as we operate in an extremely competitive market for all of our product offerings.

Robert I. Goldstein, our President, Chief Executive Officer and Chairman of the Board of Directors also maintains a position as President of Gold Team Inc., a Delaware company that invests in industrial real estate properties for investment purposes. He holds an 8% interest in Gold Team Inc. and spends approximately 5 hours per week on affairs related to Gold Team Inc. The Company leases its current facilities from Gold Team Inc., which owns both the Canoga Park, CA and Milford, Ohio properties.

On May 31, 2016, we entered into an Asset Purchase Agreement with Electronic Control Concepts (“ECC”) whereby the Company purchased certain tangible and intangible assets of ECC. ECC is a small manufacturer of test and maintenance meters for x-ray machines both medical and industrial. We acquired ECC to give a boost to our current x-ray related product and hospital/medical product sales.

On March 3, 2023, the Company divested itself of its wholly owned subsidiary, Cali From Above, through a Membership Interest Purchase Agreement with the Company’s President and Chief Executive Officer, Robert Goldstein. Consideration received by the Company was 65,000,000 shares of Averox, Inc. (OTC:AVRI), resulting in the Company owning 26% of the issued and outstanding shares of common stock of AVRI. The Company and Cali From Above also signed a Cooperation Agreement whereby the Company holds exclusive sourcing and manufacturing rights for Cali From Above products, thus making Cali From Above a new customer of the Company.

Results of Operations

For the three months ended March 31, 2026, compared to the three months ended March 31, 2025:

	Three Months Ended March 31,			Change
	2026			2025			$		%

Sales	$	352,209			$	476,705		$	(124,496	)	-26.1	%
Cost of goods sold		197,214				127,788			69,426		54.3	%
Gross profit		154,995				348,917			(193,922	)	-55.6	%
Selling, general and administrative expenses		300,898				872,797			(571,899	)	-65.5	%
Loss from operations		(145,903	)			(523,880	)		377,977		-72.1	%
Other expense		(41,183	)			(36,352	)		(4,831	)	13.3	%
Loss before provision for income taxes		(187,086	)			(560,232	)		373,146		-66.6	%
Provision for income taxes		-				-			-
Net loss	$	(187,086	)		$	(560,232	)	$	373,146		-66.6	%

Sales for the three months ended March 31, 2026, were $352,209 compared to $476,705 for the same period in 2025. The decrease of $124,496 or 26.1% is largely a result of a decrease in sales at our Overhoff subsidiary of $135,369 offset by an increase in sales at our Optron facility of $10,873. Sales from period to period are also dependent on the mix of products and services sold during the period. The geographic breakdown in sales during the three months ending March 31, 2026, is as follows:

North America 57.76%

Asia (Including Japan) 8.54%

Other 33.7%

Our gross margins for the three months ended March 31, 2026, were 44.01% as compared to 73.19% for the same period in 2025. Gross margins decreased for the three months ending March 31, 2026, by $193,922. This compression was primarily driven by an approximate $65,000 increase in indirect labor costs allocated to manufacturing overhead during the current quarter, which resulted in unfavorable production cost absorption. The remaining variance was driven by a shift in revenue mix between lower-margin services and higher-margin products, as well as inflationary fluctuations in raw material costs.

Selling, general and administrative expenses for the three months ended March 31, 2026, were $300,898 compared to $872,797 for the same period in 2025. The decrease of $571,899 or 65.5% was principally due to $451,099 in stock-based compensation as well as decreases in professional fees and commissions. Stock based compensation is issued for advisory services and as an incentive to consultants to increase revenues through the acquisition of new customers.

Other expense for the three months ended March 31, 2026, was $41,183 compared to $36,352 for the same period in 2025 and reflects interest expense incurred during the period.

Liquidity and Capital Resources

Our operations have historically been financed by our majority shareholder and more recently from proceeds from the sale of our common stock. As funds were needed for working capital purposes, our majority shareholder would loan us the needed funds. We anticipate funding the growth of our business through the sales of additional shares of our common stock and loans from our majority stockholder if necessary.

Total assets decreased by $282,934 to $1,638,950 at March 31, 2026, compared to $1,921,883 at December 31, 2025. This decrease was primarily driven by lower accounts receivable balances and a reduction in inventories.

Total liabilities decreased by $56,553 to $2,379,021 at March 31, 2026, compared to $2,435,574 at December 31, 2025. This net decrease was primarily driven by reductions in customer deposits, accounts payable, and notes payable, which were partially offset by increases in accrued liabilities, accrued officer compensation, and credit facility borrowings.

Net cash used in operating activities for the three months ended March 31, 2026, was $126,563 compared to $92,486 for the same period in 2025. The change in cash used in operations was principally due to changes in inventory, accounts receivable, accounts payable, and customer deposit working capital accounts.

Net cash used in investing activities was $0 for both the three months ended March 31, 2026, and March 31, 2025.

Net cash provided by financing activities for the three months ended March 31, 2026, was $59,102 compared to $30,135 for the same period in 2025. The increase in cash from financing activities was primarily driven by increases to borrowing under our lines of credit and notes payable, offset by a reduction in proceeds from the sale of common stock.

Critical Accounting Policies

Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (“US GAAP”). US GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expenses amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.

We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently applied. Our significant accounting policies are summarized in Note 2 to our consolidated financial statements.

Income Taxes

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

None

Item 4. Controls and Procedures.

Evaluation of disclosure controls and procedures

Under the supervision and with the participation of our management, including our principal executive officer and the principal financial officer, we are responsible for conducting an evaluation of the effectiveness of the design and operation of our internal controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the fiscal quarter covered by this report. Disclosure controls and procedures means that the material information required to be included in our Securities and Exchange Commission (“SEC”) reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, particularly during the period when this report was being prepared. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective as of March 31, 2026.

Changes in internal controls

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, performed an evaluation to determine whether any change in our internal controls over financial reporting occurred during the three-month period ended March 31, 2026. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company’s internal controls over financial reporting during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

There are not presently any material pending legal proceedings to which the Company is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

Item 1A. Risk Factors

See our Form 10K filed on June 23, 2026, for Risk Factors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 7, 2025, the Company issued 2,580,460 common shares for debt and interest for a value of $154,828, or $0.06 per share.

On January 16, 2025, the Company issued 650,000 shares to its CFO as compensation for services for a value of $50,700, or $0.078 per share.

On January 16, 2025, the Company issued 200,000 shares to a consultant for services for a value of $14,000, or $0.07 per share.

On January 24, 2025, the Company issued 1,786,966 common shares for debt and interest for a value of $107,218, or $0.06 per share, and the note was considered paid in full.

On March 6, 2025, the Company issued 1,000,000 common shares for $50,000 cash, or $0.05 per share. On March 19, 2025, the Company issued an additional 834,000 common shares in error, related to the March 6, 2025 transaction, and the Company is working with the transfer agent to cancel the shares.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Incorporated by reference

Exhibit

Exhibit Description

Filed
herewith

Form

Period
ending

Exhibit

Filing date

3.1

Certificate of Incorporation

3.1

03/02/2012

3.2

By-Laws

3.2

03/02/2012

3.3

Amendment to Certificate of Incorporation

8-K

3.3

05/29/2012

3.4

Certificate of Designation of Preferred Shares

10-Q

3.4

11/27/2024

4.1

Specimen Stock Certificate

4.1

03/02/2012

10.1

Robert I. Goldstein Employment Agreement

10-Q

10.1

11/11/2014

10.2

Forgiveness of Debt and Conversion Agreement

10-Q

10.2

11/11/2014

31.1

Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.2

Certification pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	US Nuclear Corp

	By:	/s/ Robert Goldstein
		President, Chief Executive Officer, Chairman of the Board of Directors

	By:	/s/ Michael Hastings
		Chief Financial Officer and Director

Date: October 13, 2026

","original","zhKind","translation","complete",false,"公司与财报","宏观与美联储","政策与监管","其他","市场观察","观点与解读","aihot","/items/wia2cl2nvaxiji5dpkxg5xgbt","https://www.sec.gov/Archives/edgar/data/1543623/000121390026108835/0001213900-26-108835-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1792108800&sig=e4adf00b596060d2","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1792108800&sig=208b33ec2756b0ea 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1792108800&sig=786fcd6a5ff8379c 96w","changelogVersion","2026-10-01T08:00"]